Ines Boussen

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas.

Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas.

Journal: Journal of neurology
Published: April 27, 2026

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy.

Journal: Journal of neurology
Published: January 05, 2026

Oral Plasmablastic Lymphoma: Case Series and Literature Review.

Oral Plasmablastic Lymphoma: Case Series and Literature Review.

Journal: Head & neck
Published: July 20, 2025

Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study.

Preliminary evidence of CAR T-cell therapy activity in vitreoretinal lymphomas: An LOC network study.

Journal: HemaSphere
Published: April 20, 2025

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Neurotoxicity in Patients With CNS Lymphomas Treated With CAR T-Cell Therapy: A Study From the French Oculo-Cerebral Lymphoma Network.

Journal: Neurology
Published: March 27, 2025

Long-term outcome following vertebroplasty or bone cementoplasty in multiple myeloma patients.

Long-term outcome following vertebroplasty or bone cementoplasty in multiple myeloma patients.

Journal: Neuroradiology
Published: February 25, 2025

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.

Tandem combination of ASCT and CAR T-cell therapy in highly refractory CNS lymphomas.

Journal: British journal of haematology
Published: February 05, 2025

Mild Metabolism Increase on Posttreatment 18 F-FDG PET may Indicate Recurrence of Primary CNS Lymphoma.

Mild Metabolism Increase on Posttreatment 18 F-FDG PET may Indicate Recurrence of Primary CNS Lymphoma.

Journal: Clinical nuclear medicine
Published: February 04, 2025

Human T-Lymphotropic Virus-1 Associated With Adult T-Cell Lymphoma: A Case Report.

Human T-Lymphotropic Virus-1 Associated With Adult T-Cell Lymphoma: A Case Report.

Journal: Cureus
Published: November 14, 2024

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study.

Journal: Blood advances
Published: July 29, 2024

Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.

Prognostic Value of CSF IL-10 at Early Assessment of Induction Chemotherapy in Primary CNS Lymphomas: A LOC Network Study.

Journal: Neurology
Published: June 03, 2024

Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.

Primary central nervous system lymphomas in immunocompromised patients require specific response criteria.

Journal: Journal of neuro-oncology
Published: March 23, 2024
Showing 1-12 of 20

Last Updated: 09/26/2026